Overview
Emir Sajjad practices practicing medicine in Warsaw, Poland.
His clinical expertise encompasses Hypothalamic Tumor, Pituitary Tumor, Brain Tumor, and Nelson Syndrome.
He is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Emir A. Sajjad
Is Emir A. Sajjad a top-rated expert for Hypothalamic Tumor?
MediFind is an objective health platform that identifies experts based on real-world data. Emir A. Sajjad is classified as an Experienced expert for Hypothalamic Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Emir A. Sajjad participate in research or clinical trials?
Yes. Emir A. Sajjad has published 11 articles and abstracts on conditions like Hypothalamic Tumor. You can view a list of Emir A. Sajjad's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Brain TumorMr. Sajjad isExperienced. Learn about Brain Tumor.
- Hypothalamic TumorMr. Sajjad isExperienced. Learn about Hypothalamic Tumor.
- Nelson SyndromeMr. Sajjad isExperienced. Learn about Nelson Syndrome.
- Pituitary TumorMr. Sajjad isExperienced. Learn about Pituitary Tumor.